 |
Avigen drug fails trial (BizJournals) |
Avigen Inc. said a study of its drug to control spasticity in multiple sclerosis patients failed a midstage trial. (AVGN)
More: continued here
This entry was posted on Wednesday, October 22nd, 2008 and is filed under Drug Addiction. You can follow any responses to this entry through the RSS 2.0 feed. You can leave a response, or trackback from your own site.
Leave a comment